Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michael Valente"'
Autor:
Michael Valente, Eliézer Jäger, N. Koen van Riessen, Eric A. W. van Dinther, Uzi Gileadi, Carl G. Figdor, Martin Hruby, Vincenzo Cerundolo, Oya Tagit, Yusuf Dolen
Publikováno v:
Oncoimmunology, 9
Oncoimmunology, 9, 1
OncoImmunology
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)
Oncoimmunology, 9, 1
OncoImmunology
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 9, Iss 1 (2020)
Nanovaccines, co-delivering antigen and invariant natural killer T (iNKT) cell agonists, proved to be very effective in inducing anti-tumor T cell responses due to their exceptional helper function. However, it is known that iNKT cells are not equall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5034b5a0bc039fa9cecc1d3c3459eca7
http://hdl.handle.net/2066/217382
http://hdl.handle.net/2066/217382
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 70
We present a case demonstrating histopathological clot findings after endovascular thrombectomy for acute ischaemic stroke in a 38 year-old male with systemic lupus erythematosus and antiphospholipid syndrome (APS). The differential diagnosis was emb
Publikováno v:
The Laryngoscope. 129:1023-1024
Autor:
Michael Valente
Publikováno v:
Trends in Amplification. 4:112-135
Because of the improvement in SNR reported for dual microphones in the studies reviewed in this manuscript, it is felt that a greater number of manufacturers will be releasing producis containing dual-microphone technology in the near future. For exa
Autor:
Michael Valente, Dennis VanVliet
Publikováno v:
Trends in Amplification. 2:6-35
The Independent Hearing Aid Fitting Forum (IHAFF) protocol was developed between 1993 and 1994 during numerous weekend meetings in Denver, Tampa, Anaheim and Chicago. The protocol was the brainchild of Dennis Van Vliet and Michael Marion, who were fr
Autor:
Duco van Dalen, Camille M. Le Gall, Tomislav Čaval, Johan M.S. van der Schoot, Anouk M. D. Becker, Michael Valente, J. Armando C. van Bruggen, Ferenc A. Scheeren, Carl G. Figdor, Marieke F. Fransen, Yusuf Dolen, Martijn Verdoes, Iris M. Hagemans, Maaike Nederend, Gestur Vidarsson, Jeanette H. W. Leusen, Albert J. R. Heck, Felix L. Fennemann, Arthur E. H. Bentlage, Melanie Engelfriet, Alper Cevirgel
Publikováno v:
bioRxiv
Hybridoma technology is instrumental for the development of novel antibody therapeutics and diagnostics. Recent preclinical and clinical studies highlight the importance of antibody isotype for therapeutic efficacy. However, since the sequence encodi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90310b3ac8f789fea72911dd3d9ee2b0